GEMCITABINE and PYREXIA

Overview

PYREXIA is the #9 most commonly reported adverse reaction for GEMCITABINE, manufactured by Accord Healthcare Inc.. There are 1,898 FDA adverse event reports linking GEMCITABINE to PYREXIA. This represents approximately 2.7% of all 70,539 adverse event reports for this drug.

Patients taking GEMCITABINE who experience pyrexia should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

PYREXIA is a less commonly reported adverse event for GEMCITABINE, but still significant enough to appear in the safety profile.

Other Side Effects of GEMCITABINE

In addition to pyrexia, the following adverse reactions have been reported for GEMCITABINE:

• DISEASE PROGRESSION — 4,353 reports
• THROMBOCYTOPENIA — 2,861 reports
• OFF LABEL USE — 2,622 reports
• NEUTROPENIA — 2,556 reports
• DRUG INEFFECTIVE — 2,512 reports
• ANAEMIA — 2,338 reports
• MALIGNANT NEOPLASM PROGRESSION — 2,005 reports
• NAUSEA — 1,936 reports
• FATIGUE — 1,610 reports
• DIARRHOEA — 1,584 reports

Other Drugs Associated with PYREXIA

The following drugs have also been linked to pyrexia in FDA adverse event reports:

Does GEMCITABINE cause PYREXIA?

PYREXIA has been reported as an adverse event in 1,898 FDA reports for GEMCITABINE. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is PYREXIA with GEMCITABINE?

PYREXIA accounts for approximately 2.7% of all adverse event reports for GEMCITABINE, making it a notable side effect.

What should I do if I experience PYREXIA while taking GEMCITABINE?

If you experience pyrexia while taking GEMCITABINE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages